Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
The interface of pain and mood disturbances in the rheumatic diseases
Seminars in Arthritis and Rheumatism, 06/30/09
Goldenberg DL et al. – This review provides a basis for understanding the importance of the pain/depression interface in the rheumatic illnesses. Clinical and pathophysiologic studies in fibromyalgia (FM) demonstrate the striking overlap of pain and depression.
Methods- Aim was to review:
- Overlap of pain and depression in the rheumatic diseases, focusing on FM and RA, and
- To provide treatment recommendations based on an understanding of this interface
- A literature search was performed through PubMed and Medline, for the yrs 1978 to 2008
- Keywords used: depression, mood disorders, pain, arthritis, fibromyalgia, rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, scleroderma, antidepressants, exercise, and cognitive behavioral therapy
- Review focuses on the pain/depression interface in common rheumatic disorders; treatment principles are outlined as:
- Pain and depression are inseparable, bidirectional
- Explain to patients the shared neurobiology of pain and depression
- Always evaluate and treat sleep disturbances
- “Bundle” the treatment of mood disturbances with physical symptoms carefully
- Use diagnostic labels cautiously; avoid causation
- Avoid inactivity, fear-avoidance
- Neural pain dysregulation is prominent in all rheumatic diseases (FM model)
- General therapeutic recommendations can be made based on these overlapping models of the interface of pain and depression
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute Coronary Syndromes: Diagnosis and Management, Part I
Mayo Clinic Proceedings, 10/05/09
New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Management of agitation and aggression associated with Alzheimers disease: controversies and possible solutions
Current Opinion in Psychiatry, 10/12/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


